Our Portfolio Prioritization service helps pharmaceutical companies optimize their development portfolios through rigorous, data-driven analysis. We combine clinical probability of success, commercial potential, regulatory risk, and strategic fit into a comprehensive valuation framework.
How our portfolio prioritization service delivers value to your organization.
Comprehensive asset valuation incorporating clinical, commercial, regulatory, and manufacturing risk factors.
Model multiple portfolio scenarios with different investment levels, development timelines, and risk profiles.
Optimize R&D resource allocation across assets to maximize portfolio value within budget constraints.
Evaluate each asset against your corporate strategy, therapeutic area focus, and capability gaps.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Profile each asset with clinical stage, mechanism, indication, and development timeline.
Calculate risk-adjusted NPV with probability of success by phase and therapeutic area.
Run portfolio optimization models to identify the highest-value resource allocation.
Deliver prioritized investment recommendations with supporting analysis and scenario comparisons.
We use risk-adjusted NPV (rNPV) as the primary valuation method, incorporating phase-specific probability of success, peak sales estimates, and development cost projections.
Yes, we model multiple scenarios with different budget constraints, development timelines, and risk tolerance levels to support strategic decision-making.
We use historical phase transition success rates by therapeutic area, combined with asset-specific risk factors such as trial design, endpoint selection, and competitive landscape.
Track global drug pipelines across 190+ markets with phase progression analysis, competitive landscaping, and predictive scoring.
Learn moreEvaluate therapeutic area opportunities with disease burden analysis, treatment landscape mapping, and unmet need quantification.
Learn moreDetailed market sizing, forecasting, and competitor positioning to identify white space and launch opportunities.
Learn moreConnect with our team to discuss how our portfolio prioritization service can support your goals.
Schedule a Consultation